Helen Yang, Oricell CEO

In push to ex­pand its CAR-T ther­a­pies to US, Chi­na biotech Ori­cell rais­es ad­di­tion­al $45M

Shang­hai biotech Ori­cell has raised an ad­di­tion­al $45 mil­lion to bankroll its pre­clin­i­cal and ear­ly-stage can­cer cell ther­a­pies, it an­nounced Tues­day …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.